Chemotherapy-induced recovery?
I would like to ask, every time before administering chemotherapy drugs, the nursing staff confirms blood return.
Is it necessary to check for blood return again during the infusion process?
luc, 20~29 year old female. Ask Date: 2017/07/05
Dr. Hu Ziren reply Oncology
Before administering the injection, aspirating is done to ensure that the catheter is patent; therefore, it is sufficient to confirm this before the injection.
There is no need to continuously check during the injection process.
Reply Date: 2017/07/05
More Info
When undergoing chemotherapy infusions, it is indeed crucial to monitor the blood return, also known as blood return verification, before and during the infusion process. This practice is essential for several reasons, primarily to ensure the safety and effectiveness of the treatment.
Understanding Blood Return Verification:
Blood return verification is the process where healthcare providers check for the return of blood from the intravenous (IV) line back into the syringe or IV bag. This step is critical because it confirms that the IV line is correctly positioned in the vein and that there are no blockages or complications, such as infiltration (when the IV fluid leaks into the surrounding tissue) or extravasation (when the chemotherapy drug leaks into surrounding tissue, potentially causing damage).
Why Check Blood Return Before Infusion:
1. Confirming IV Patency: Before administering chemotherapy, it is vital to ensure that the IV line is patent (open and unobstructed). If the line is not patent, the chemotherapy may not be delivered effectively, which could lead to inadequate treatment.
2. Preventing Complications: Checking for blood return helps prevent complications associated with chemotherapy administration. If there is no blood return, it may indicate that the catheter is not in the correct position, which could lead to serious complications if chemotherapy is administered.
3. Patient Safety: Ensuring that the IV line is functioning correctly before starting the infusion is a critical safety measure. It helps protect the patient from potential adverse effects that could arise from improper administration of chemotherapy.
Should Blood Return Be Checked During Infusion?
While the primary checks are typically done before the infusion, it is also advisable to monitor the IV line during the infusion process. Here are some reasons why:
1. Monitoring for Complications: During the infusion, healthcare providers should observe for any signs of complications, such as swelling, redness, or pain at the infusion site. If any of these symptoms occur, checking for blood return can help determine if the IV line is still functioning correctly.
2. Adjusting Infusion Rates: If there are any changes in the flow rate of the chemotherapy infusion, checking for blood return can help assess whether the IV line is still patent. If the flow rate decreases unexpectedly, it may indicate a blockage or other issue.
3. Ensuring Effective Delivery: Continuous monitoring during the infusion can help ensure that the chemotherapy is being delivered effectively and that the patient is tolerating the treatment well.
Conclusion:
In summary, while the initial blood return verification is essential before starting chemotherapy, ongoing monitoring during the infusion is also important. This practice helps ensure patient safety, effective treatment delivery, and the early detection of any potential complications. Nurses and healthcare providers are trained to recognize the signs of complications and will take appropriate action if any issues arise during the infusion process. If you have any concerns or questions about your chemotherapy treatment, it is always best to discuss them with your healthcare team, who can provide personalized guidance based on your specific situation.
Similar Q&A
Understanding Chemotherapy Decisions for Elderly Cancer Patients
Dear Dr. Fan, My mother is 78 years old and discovered a lump in her breast in February. She underwent surgery at Dalin Tzu Chi Hospital, where a biopsy confirmed it was cancer. A few weeks after the surgery, we received the pathology report, which indicated it was stage II and ...
Dr. Fan Sheng reply Oncology
Dear Mr. Yuan, Hello. First of all, considering your mother's age, it is highly likely that her breast cancer specimen's estrogen receptor (ER) is positive. If this is the case, I recommend administering the oral estrogen receptor antagonist Tamoxifen for two years, fo...[Read More] Understanding Chemotherapy Decisions for Elderly Cancer Patients
What to Know About Abnormal Blood Test Results in Oncology
I would like to ask the doctor about the red-highlighted areas (the parts in parentheses) what I should pay attention to? Is further examination necessary? (MCHC 27.5) (MCV 71.4) MPV 9.4 Platelet 300 RBC 4.33 (RDW 19.7) WBC 4.10 Basophil 0.2 (Eosinophil 0.2) Lymphocyte 24.6 Monoc...
Dr. Chen Yunfang reply Oncology
Hello: (Hb 8.5) (MCV 71.4) indicates anemia. Please see a physician for medication. Thank you.[Read More] What to Know About Abnormal Blood Test Results in Oncology
Understanding Blood Counts in Myeloid Leukemia: Key Insights for Patients
Dear Dr. Chen, I have been diagnosed with myelodysplastic syndrome (the doctor mentioned it is on the verge of becoming acute). After that, I underwent treatment for two months (subcutaneous injection of targeted therapy), with weekly blood tests. The doctor informs me of my whi...
Dr. Chen Yunfang reply Oncology
Hello: Although you did not explicitly state your diagnosis, based on your description, I suspect you may have been diagnosed with myelodysplastic syndrome (MDS). Our hematologists consider MDS to be a precursor to blood cancer, and if left untreated, there is a significant chanc...[Read More] Understanding Blood Counts in Myeloid Leukemia: Key Insights for Patients
Understanding Blood Test Results: Insights into Tumor-Related Concerns
Hello Doctor, last week I went to the emergency room due to headaches and dizziness. The blood test report showed CBC 8.95 10^3/µL, SEG 26.3%, LYMPH 55.4%, MONO 10.7%, PDW 9.2 fL, and other values were within the standard range. I have researched hematological symptoms and found ...
Dr. Chen Yunfang reply Oncology
Hello: Based on the blood test results you provided, there does appear to be a hematological issue. The most significant concern is the elevated percentage of lymphocytes, which accounts for 55.4% of the total white blood cell count. This is abnormal, as the normal range for lymp...[Read More] Understanding Blood Test Results: Insights into Tumor-Related Concerns
Related FAQ
(Oncology)
Blood(Oncology)
Thalassemia(Oncology)
Side Effects Of Chemotherapy(Oncology)
Thrombocytosis(Oncology)
Blood Draw(Internal Medicine)
Lymphadenopathy(Oncology)
Blood Test(Gastroenterology and Hepatology)
Which Department Should I See?(Oncology)
Blood Test(Cardiology)